Italy approves Israeli coronavirus treatment

Italy has approved Opaganib from Israel’s Redhill Biopharma to treat some 160 severe COVID-19 patients with severe respiratory problems at three hospitals in northern Italy. Phase2 tests on 131 US patients were positive and two critically ill Israeli patients are improving.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *